[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
January 1993

Silicone-Associated Connective-Tissue DiseaseThe Debate Rages

Author Affiliations

Division of Dermatology and Cutaneous Surgery; Division of Rheumatology University of South Florida College of Medicine MDC Box 19 12901 Bruce B. Downs Blvd Tampa, FL 33612

Arch Dermatol. 1993;129(1):97-98. doi:10.1001/archderm.1993.01680220109024
Abstract

The current lack of definitive information concerning the relationship of silicone breast implants and rheumatic disease represents a massive failure of industry, government, and medicine. Although it is estimated that two million women have been implant recipients, it is disconcerting that the exact number is unknown. Unfortunately, these women are frightened by the considerable publicity generated by legislative hearings questioning the safety of silicone implants as a newly responsible government now struggles with developing regulations for devices that have been in use for approximately 30 years.

Manufacturers and many plastic surgeons have taken the position that the long-term clinical use of silicone breast implants without obvious evidence of adverse reactions is, by itself, adequate support for the safety of these prostheses. When concerns regarding the safety of these devices surfaced, investigators were chagrined to find that no controlled long-term studies of women with breast implants were published. The best available

First Page Preview View Large
First page PDF preview
First page PDF preview
×